Nothing Special   »   [go: up one dir, main page]

ES494222A0 - Procedimiento para la preparacion de derivados de cinamoil- piperidinobutirofenona - Google Patents

Procedimiento para la preparacion de derivados de cinamoil- piperidinobutirofenona

Info

Publication number
ES494222A0
ES494222A0 ES494222A ES494222A ES494222A0 ES 494222 A0 ES494222 A0 ES 494222A0 ES 494222 A ES494222 A ES 494222A ES 494222 A ES494222 A ES 494222A ES 494222 A0 ES494222 A0 ES 494222A0
Authority
ES
Spain
Prior art keywords
piperidinobutyrophenone
cinamoil
derivatives
procedure
preparation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES494222A
Other languages
English (en)
Other versions
ES8106143A1 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Richardson Vicks Inc
Original Assignee
Richardson Merrell Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Richardson Merrell Inc filed Critical Richardson Merrell Inc
Publication of ES8106143A1 publication Critical patent/ES8106143A1/es
Publication of ES494222A0 publication Critical patent/ES494222A0/es
Granted legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/18Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D211/30Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by doubly bound oxygen or sulfur atoms or by two oxygen or sulfur atoms singly bound to the same carbon atom
    • C07D211/32Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by doubly bound oxygen or sulfur atoms or by two oxygen or sulfur atoms singly bound to the same carbon atom by oxygen atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/20Hypnotics; Sedatives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/60Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D211/62Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals attached in position 4

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Anesthesiology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
ES494222A 1979-09-04 1980-08-13 Procedimiento para la preparacion de derivados de cinamoil- piperidinobutirofenona Granted ES494222A0 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/072,498 US4284636A (en) 1979-09-04 1979-09-04 Cinnamoylpiperidinobutyrophenone antipsychotic agents

Publications (2)

Publication Number Publication Date
ES8106143A1 ES8106143A1 (es) 1981-08-01
ES494222A0 true ES494222A0 (es) 1981-08-01

Family

ID=22107979

Family Applications (1)

Application Number Title Priority Date Filing Date
ES494222A Granted ES494222A0 (es) 1979-09-04 1980-08-13 Procedimiento para la preparacion de derivados de cinamoil- piperidinobutirofenona

Country Status (14)

Country Link
US (1) US4284636A (es)
JP (1) JPS5640665A (es)
AU (1) AU533712B2 (es)
BE (1) BE885017A (es)
CA (1) CA1147734A (es)
CH (1) CH646691A5 (es)
DE (1) DE3031892A1 (es)
ES (1) ES494222A0 (es)
FR (1) FR2464251A1 (es)
GB (1) GB2057445B (es)
IL (1) IL60739A (es)
IT (1) IT1145444B (es)
NL (1) NL8004837A (es)
ZA (1) ZA804661B (es)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3245190B1 (en) 2015-01-16 2018-12-26 Bayer CropScience Aktiengesellschaft Method for preparing 4-cyanopiperidine hydrochloride
EP3553179A1 (en) 2018-04-12 2019-10-16 Universität Bielefeld Enantioselective biocatalytic preparation of 4-cyano-substituted 1-aminoindane and ozanimod

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3080372A (en) * 1960-03-25 1963-03-05 Res Lab Dr C Janssen 1-aroylalkyl-4-arylpiperidine derivatives
US3816433A (en) * 1965-03-24 1974-06-11 Ferrosan Ab 4-fluoro-ypsilon-(4-methylpiperidino)-butyrophenone and its pharmaceutically acceptable salts
US3689492A (en) * 1965-09-10 1972-09-05 Hans Detlef Schroeder 1-{8 4{40 -OXO-4-(p-FLUOROPHENYL)-n-BUTYL-1{40 {9 -4-ACETYL-4-(m-HYDROXY-PHENYL-PIPERIDINE
US3646014A (en) * 1966-05-09 1972-02-29 Aldrich Chem Co Inc Chemical compounds
US3484446A (en) * 1967-01-16 1969-12-16 Aldrich Chem Co Inc 1-(3-(4-fluorobenzoyl)propyl) - and 1 - (1,1-ethylenedioxy - 1 - (4 - fluorophenyl)-4-butyl)-4-piperidyl carbamates
NL130760C (es) * 1967-01-25
CH516557A (de) 1967-12-01 1971-12-15 Thomae Gmbh Dr K Verfahren zur Herstellung neuer Zimtsäureamide
CH532049A (de) * 1967-12-01 1973-02-15 Thomae Gmbh Dr K Verfahren zur Herstellung von neuen Zimtsäureamiden
US3576810A (en) * 1968-06-20 1971-04-27 Robins Co Inc A H 1-substituted-3-(-4)-aroylpiperidines
US3637712A (en) * 1970-01-26 1972-01-25 Bristol Myers Co Piperidylpropanol compounds
US3799932A (en) * 1970-03-20 1974-03-26 Sumitomo Chemical Co Gamma-piperidinobutyrophenones
ZA717147B (en) * 1970-11-27 1972-07-26 Richardson Merrell Inc 4-(4-(alpha-hydroxybenzyl)piperidino)-4'-fluorobutyrophenone derivatives
US4101662A (en) * 1973-05-03 1978-07-18 A. H. Robins Company, Incorporated Method for inhibiting emesis and compositions therefor
SE7409245L (es) * 1973-07-19 1975-01-20 Robins Co Inc A H
GB1535791A (en) * 1975-05-07 1978-12-13 Ferrosan Ab Derivatives of 4-piperidinol
CH602642A5 (es) * 1975-11-14 1978-07-31 Orgamol Sa

Also Published As

Publication number Publication date
ES8106143A1 (es) 1981-08-01
CA1147734A (en) 1983-06-07
GB2057445A (en) 1981-04-01
GB2057445B (en) 1983-11-30
IL60739A (en) 1984-02-29
FR2464251A1 (fr) 1981-03-06
DE3031892A1 (de) 1981-03-19
BE885017A (fr) 1980-12-31
IT8049544A0 (it) 1980-08-22
ZA804661B (en) 1981-07-29
AU533712B2 (en) 1983-12-08
CH646691A5 (de) 1984-12-14
FR2464251B1 (es) 1983-05-20
IL60739A0 (en) 1980-10-26
JPS6344147B2 (es) 1988-09-02
JPS5640665A (en) 1981-04-16
NL8004837A (nl) 1981-03-06
AU6149180A (en) 1981-03-12
IT1145444B (it) 1986-11-05
US4284636A (en) 1981-08-18

Similar Documents

Publication Publication Date Title
ES489934A0 (es) Procedimiento para la preparacion de derivados de pipreridi-na
ES490536A0 (es) Procedimiento para la preparacion de derivados de la glici- namida
ES498224A0 (es) Procedimiento para la preparacion de sulfonilureas
ES491913A0 (es) Procedimiento para la preparacion de betainas
ES492891A0 (es) Procedimiento para la preparacion de derivados triyodados deacido 5-amino- isoftalico
AR227645A1 (es) Procedimiento para la preparacion de oxoalcohilxantinas
ES492566A0 (es) Procedimiento para la preparacion de nuevos derivados de en-cafalina
ES495179A0 (es) Procedimiento para la preparacion de polieterpoliaminas
ES493774A0 (es) Procedimiento para la preparacion de 3-amino-sidnoniminas
ES497100A0 (es) Procedimiento para la preparacion de sulfonilureas
ES491142A0 (es) Procedimiento para la preparacion de derivados de fenileti- lamina
ES491154A0 (es) Procedimiento para la preparacion de derivados furanonicos
ES493300A0 (es) Procedimiento para la preparacion de acilureas
ES487746A0 (es) Procedimiento para la preparacion de bis-estiril-benceno
MX6221E (es) Procedimiento para la preparacion de derivados de homoserina
ES494856A0 (es) Procedimiento para la preparacion de n-aril-n-acil-3-amino- oxazolidin-2-onas
ES490420A0 (es) Procedimiento para la preparacion de diestirilbifenilos
ES490421A0 (es) Procedimiento para la preparacion de diestirilbencenos
ES491527A0 (es) Procedimiento para la preparacion de tiazoliliden-oxo-pro- pionitrilos
AR225159A1 (es) Procedimiento para la preparacion de l-alpha-gliceril-fosforilcolina
ES490620A0 (es) Procedimiento para la preparacion de 3-alcoxi-6-alquiliden- hidracionopiridacina
ES497659A0 (es) Procedimiento para la preparacion de sulfonilureas
AR224518A1 (es) Procedimiento para la preparacion de derivados de 1-piperidino-ftalazina
ES493001A0 (es) Procedimiento para la preparacion de metilglioxal
AR223383A1 (es) Procedimiento para la preparacion de 2-isopropilamino-pirimidina

Legal Events

Date Code Title Description
FD1A Patent lapsed

Effective date: 19970519